Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of hepatitis C virus core encoding sequences in chronically infected patients reveals mutability, predominance, genetic history and potential impact on therapy of Cuban genotype 1b isolates.
González-Horta EE, Marante J, Amador-Cañizares Y, Alvarez-Lajonchere L, Guerra I, Martínez-Donato G, Dueñas-Carrera S. González-Horta EE, et al. Among authors: amador canizares y. Eur Rev Med Pharmacol Sci. 2011 Nov;15(11):1320-7. Eur Rev Med Pharmacol Sci. 2011. PMID: 22195367
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
Alvarez-Lajonchere L, Shoukry NH, Grá B, Amador-Cañizares Y, Helle F, Bédard N, Guerra I, Drouin C, Dubuisson J, González-Horta EE, Martínez G, Marante J, Cinza Z, Castellanos M, Dueñas-Carrera S. Alvarez-Lajonchere L, et al. J Viral Hepat. 2009 Mar;16(3):156-67. doi: 10.1111/j.1365-2893.2008.01058.x. Epub 2008 Oct 31. J Viral Hepat. 2009. PMID: 19017255 Clinical Trial.
HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.
Amador-Cañizares Y, Martínez-Donato G, Alvarez-Lajonchere L, Vasallo C, Dausá M, Aguilar-Noriega D, Valenzuela C, Raíces I, Dubuisson J, Wychowski C, Cinza-Estévez Z, Castellanos M, Núñez M, Armas A, González Y, Revé I, Guerra I, Pérez Aguiar A, Dueñas-Carrera S. Amador-Cañizares Y, et al. World J Gastroenterol. 2014 Jan 7;20(1):148-62. doi: 10.3748/wjg.v20.i1.148. World J Gastroenterol. 2014. PMID: 24415868 Free PMC article. Clinical Trial.
Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
Alvarez-Lajonchere L, Amador-Cañizares Y, Frías R, Milian Y, Musacchio A, Guerra I, Acosta-Rivero N, Martínez G, Castro J, Puentes P, Cosme K, Dueñas-Carrera S. Alvarez-Lajonchere L, et al. Biotechnol Appl Biochem. 2008 Oct;51(Pt 2):97-105. doi: 10.1042/BA20070182. Biotechnol Appl Biochem. 2008. PMID: 18215116
Toxicology and biodistribution study of CIGB-230, a DNA vaccine against hepatitis C virus.
Bacardí D, Amador-Cañizares Y, Cosme K, Urquiza D, Suárez J, Marante J, Viña A, Vázquez A, Concepción J, Pupo M, Aldana L, Soria Y, Romero J, Madrigal R, Martínez L, Hernández L, González I, Dueñas-Carrera S. Bacardí D, et al. Among authors: amador canizares y. Hum Exp Toxicol. 2009 Aug;28(8):479-91. doi: 10.1177/0960327109106438. Epub 2009 Sep 7. Hum Exp Toxicol. 2009. PMID: 19736277
12 results